000			01773 a2200445 4500
005			20250516162731.0
264		0	_c20140607
008			201406s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.1093 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Limin
245	0	0	_aTargeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis. _h[electronic resource]
260			_bOncotarget _cAug 2013
300			_a1158-71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarbazoles _xpharmacology
650	0	4	_aCell Growth Processes _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aFemale
650	0	4	_aG2 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aHumans
650	0	4	_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors
650	0	4	_aM Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aMAP Kinase Kinase Kinases
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMCF-7 Cells
650	0	4	_aMitogen-Activated Protein Kinases _xantagonists & inhibitors
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aReceptors, Estrogen _xbiosynthesis
650	0	4	_aTransfection
650	0	4	_aMitogen-Activated Protein Kinase Kinase Kinase 11
700	1		_aGallo, Kathleen A
700	1		_aConrad, Susan E
773	0		_tOncotarget _gvol. 4 _gno. 8 _gp. 1158-71
856	4	0	_uhttps://doi.org/10.18632/oncotarget.1093 _zAvailable from publisher's website
999			_c22963467 _d22963467